查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1977635

2026-2034年全球人工胰臟装置系统（APDS）市场规模、份额、趋势和成长分析报告

Global Artificial Pancreas Device Systems (APDS) Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

人工胰臟装置系统 (APDS) 市场预计将从 2025 年的 9.9 亿美元成长到 2034 年的 21.9 亿美元，2026 年至 2034 年的复合年增长率为 9.19%。

全球人工胰臟装置系统（APDS）市场正经历强劲成长，这主要得益于全球糖尿病患者数量的不断增加。人们对先进糖尿病管理解决方案的认知度不断提高，以及对持续血糖监测需求的日益增长，推动了该技术的普及应用。胰岛素帮浦、持续血糖监测仪和控制演算法的整合等技术进步，提高了治疗的精确度。已开发地区医疗费用支出的成长和有利的报销政策，也进一步促进了市场扩张。

关键成长要素包括老年人口的成长以及1型和2型糖尿病患者数量的增加。胰岛素自动输注封闭回路型系统的持续创新正在提高患者的便利性和血糖控制水平。医疗设备製造商与数位健康公司之间的合作正在加速产品开发。此外，患者对微创和穿戴式解决方案的日益青睐也增强了医院和居家医疗机构的需求。

未来，人工智慧的融合和感测器精度的提升可望推动市场发展。新兴国家医疗基础设施的扩建也将创造新的成长机会。各公司正致力于降低成本和产品小型化，以提高产品的可及性。随着个人化医疗和远端监测的日益普及，全球人工胰臟装置系统（APDS）市场预计将保持长期持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球人工胰臟装置系统（APDS）市场：依装置类型划分

  • 市场分析、洞察与预测
  • 阈值停止装置系统
  • 控制范围（CTR）系统
  • 目标值控制系统（CTT）

第五章 全球人工胰臟装置系统（APDS）市场：依最终使用者划分

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • 居家照护

第六章 全球人工胰臟装置系统（APDS）市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic Plc
    • Bigfoot Biomedical Inc
    • Pancreum Inc
    • Johnson & Johnson
    • Beta Bionics Inc
    • TypeZero Technologies LLC
    • Insulet Corporation
    • Diabeloop
    • Tandem Diabetes Care Inc
    • Inreda Diabetic
简介目录
Product Code: VMR112112598

The Artificial Pancreas Device Systems (APDS) Market size is expected to reach USD 2.19 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 9.19% during 2026-2034.

The Global Artificial Pancreas Device Systems (APDS) Market is witnessing robust growth due to the rising prevalence of diabetes worldwide. Increasing awareness about advanced diabetes management solutions and the need for continuous glucose monitoring are driving adoption. Technological advancements integrating insulin pumps, continuous glucose monitors, and control algorithms have improved treatment accuracy. Growing healthcare expenditure and favorable reimbursement policies in developed regions are further supporting market expansion.

Key growth drivers include the rising geriatric population and increasing cases of Type 1 and Type 2 diabetes. Continuous innovations in closed-loop systems that automate insulin delivery are enhancing patient convenience and glycemic control. Collaboration between medical device manufacturers and digital health companies is accelerating product development. Additionally, growing patient preference for minimally invasive and wearable solutions is strengthening demand across hospitals and homecare settings.

In the future, the market is expected to benefit from artificial intelligence integration and improved sensor accuracy. Expanding healthcare infrastructure in emerging economies will create new growth opportunities. Companies are focusing on cost reduction and product miniaturization to improve accessibility. As personalized medicine and remote monitoring gain traction, the Global Artificial Pancreas Device Systems (APDS) Market is projected to experience sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Threshold Suspend Device Systems
  • Control-To-Range (CTR) Systems
  • Control-To-Target (CTT) Systems

By End User

  • Hospitals
  • Clinics
  • Homecare

COMPANIES PROFILED

  • Medtronic plc, Bigfoot Biomedical Inc, Pancreum Inc, Johnson Johnson, Beta Bionics Inc, TypeZero Technologies LLC, Insulet Corporation, Diabeloop, Tandem Diabetes Care Inc, Inreda Diabetic
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Threshold Suspend Device Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Control-To-Range (CTR) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Control-To-Target (CTT) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Device Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Device Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Device Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Device Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Device Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic Plc
    • 8.2.2 Bigfoot Biomedical Inc
    • 8.2.3 Pancreum Inc
    • 8.2.4 Johnson & Johnson
    • 8.2.5 Beta Bionics Inc
    • 8.2.6 TypeZero Technologies LLC
    • 8.2.7 Insulet Corporation
    • 8.2.8 Diabeloop
    • 8.2.9 Tandem Diabetes Care Inc
    • 8.2.10 Inreda Diabetic